Showing 1 posts of 1 posts found.
Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO